Metal-organic framework modified magnetic nanoprobe and its synthesis method and application
By modifying the magnetic nanoprobe with aluminum ions-centered metal organic framework, the problems of early liver cancer screening and glycosylated peptide detection are solved, and efficient enrichment and signal enhancement of glycosylated peptides are achieved, providing effective Biomarkers are used in the diagnosis of liver cancer.
Patent Information
- Application Number
- CN202111296275.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-11-03
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2041-11-03
AI Technical Summary
The prior art is difficult to effectively screen and diagnose early liver cancer, especially when imaging detection is atypical and serum marker sensitivity is poor, and the weak ionization ability and low abundance of glycosylated peptides in mass spectrometry analysis lead to direct Difficulty in testing.
Magnetic nanoprobes modified with metal organic frameworks with aluminum ions as the center ions are used to achieve efficient enrichment of glycosylated peptides and mass spectral signal enhancement through magnetic separation and hydrophilic pore structure, simplifying experimental operations and eliminating impurity interference.
The selective isolation and enrichment of glycosylated peptides is achieved, which significantly improves the mass spectrometry signal intensity, can effectively distinguish liver cancer from normal populations in clinical samples, and provides potential biomarkers for early screening and diagnosis.
Smart Images

Figure CN116068190B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of advanced nanomaterials, and specifically relates to a metal organic framework modified magnetic nanoprobe with aluminum ions as central ions, a synthesis method thereof, and an application thereof in enriching glycosylated peptide segments in clinical samples. Background Art
[0002] Hepatocellular Carcinoma (HCC) is one of the most common malignant tumors in the world. Among all malignant tumors in my country, the incidence of liver cancer ranks fourth and the mortality rate ranks second. In addition to being affected by risk factors such as hepatitis virus infection, cirrhosis, aflatoxin exposure, and alcohol, the risk of liver cancer caused by obesity, diabetes, metabolic syndrome, and non-alcoholic fatty liver has also increased in recent years. Studies have confirmed that the prognosis of patients is closely related to the time of diagnosis. The 5-year survival rate of patients with early diagnosis and treatment of liver cancer exceeds 70%, which is much higher than that of patients with advanced liver cancer (less than 16%). Clinically, the diagnosis of early liver cancer includes imaging, pathology, and serum tumor marker detection. However, liver cancer is occult, and early imaging tests are atypical and difficult to detect (small lesions, and the sensitivity of ultrasound examination is only 63%). Alpha-fetoprotein (AFP) is a serum biomarker currently used in clinical detection of liver cancer, but the sensitivity and specificity of AFP are poor and cannot fully meet clinical needs. Therefore, it is urgent and important to discover new liver cancer biomarkers for rapid, accurate and non-invasive early screening of liver cancer.
[0003] Protein glycosylation is a very common post-translational modification of proteins in biological cells. It determines the function and metabolic pathway of proteins and plays an irreplaceable role in the metabolism, signal transduction, cell proliferation and division of human body. Abnormal glycosylation of proteins is closely related to the occurrence and development of diseases such as cancer. Therefore, specific identification of glycosylated proteins, analysis of their dynamic changes, location and distribution, etc., are conducive to the discovery of new disease biomarkers and the early screening, diagnosis and treatment of diseases. At present, the common method for analyzing glycoproteins is to analyze and detect the glycosylated peptides of their enzymatic hydrolysis products by mass spectrometry. However, due to the weak ionization ability and low abundance of glycosylated peptides, as well as the complexity of samples, it is very difficult to directly analyze and detect glycosylated peptides by mass spectrometry. Therefore, the key to successfully analyzing glycosylated proteins is to enrich and separate glycosylated peptides in complex biological samples before mass spectrometry analysis.
[0004] Metal-organic framework (MOFs) materials are a type of porous materials constructed by coordination self-assembly of organic ligands and central metal ions or metal clusters. MOFs materials have become a research hotspot in many fields because of their large surface area, strong designability, easy adjustment of pore size and environment, and easy functionalization. In the field of analytical chemistry research, selecting suitable MOFs porous materials can achieve efficient enrichment and screening of target molecules. The present invention synthesizes for the first time a metal-organic framework modified magnetic nanoprobe with aluminum ions as the central ion with strong magnetic response and large specific surface area and applies it to the separation and enrichment of glycosylated peptides. Through magnetic separation, the whole process is fast and simple. At the same time, the hydrophilic pores in the Al-MOFs metal-organic framework have a strong affinity for the target glycosylated peptide. After enrichment by the nanoprobe, the mass spectrometry signal of the target glycosylated peptide is significantly enhanced. In addition, due to the unique porous structure of the Al-MOFs material, the nanoprobe can successfully exclude large-sized interfering substances, effectively improving the enrichment efficiency of glycosylated peptides. It was applied to the analysis of clinical samples (serum of liver cancer patients and normal subjects), and satisfactory identification results were also obtained in the study of glycosylated peptides in serum. Summary of the invention
[0005] The present invention aims to provide a metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion, which has convenient and simple synthesis, good stability and good biocompatibility, and a synthesis method thereof, as well as an application thereof in the selective enrichment detection of glycosylated peptides.
[0006] The method for synthesizing a metal organic framework modified magnetic nanoprobe provided by the present invention comprises the following specific steps:
[0007] (1) Dispersing 50-200 mg of ferroferric oxide magnetic spheres with a size of 10-30 nm in 10-30 mL of n-hexane solution containing 20-50 mg of graphene oxide, ultrasonically dispersing for 1-4 hours, and magnetically separating the material;
[0008] (2) calcining the material obtained in step (1) at 400-600 °C for 2-6 h, and the obtained material is recorded as GO@Fe3O4;
[0009] (3) Dissolve 0.5-1 g 3,5-pyrazoledicarboxylic acid and 0.2-0.5 g sodium hydroxide in 50-150 mL pure water solution, sonicate for 0.5-2 h, and then preheat at 100 °C for 30 min;
[0010] (4) Add 0.8-2.1 g of aluminum chloride hexahydrate to the solution obtained in step (3) and sonicate until dissolved;
[0011] (5) The material obtained in step (2) is dispersed in the solution obtained in step (4), and the reaction is carried out at 25-100°C for 2-24h. The product is magnetically separated and washed with deionized water and anhydrous ethanol for 2-5 times, and vacuum dried at 40-80°C to obtain a metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion, which is recorded as GO@Fe3O4@MOF-303.
[0012] In step (3) of the present invention, the weight ratio of 3,5-pyrazoledicarboxylic acid to sodium hydroxide is: 1:0.3-0.5;
[0013] In step (4) of the present invention, the weight ratio of aluminum chloride hexahydrate to 3,5-pyrazoledicarboxylic acid is 1.3-2.5:1;
[0014] In step (5) of the present invention, the reaction temperature is preferably 50-100°C.
[0015] The metal organic framework modified magnetic nanoprobe with aluminum ions as central ions prepared by the present invention has a large specific surface area, a high magnetic response effect, a good hydrophilic pore structure and stable biocompatibility. The method has a highly efficient separation effect, strong enrichment selectivity and ultra-low sensitivity for glycosylated peptides, and can be used for the selective separation, enrichment and mass spectrometry identification of glycosylated peptides. The specific steps are as follows: the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion is fully mixed with the target glycosylated peptide solution, added into 80-95% acetonitrile / 1.0-2.0% trifluoroacetic acid buffer, dispersed evenly, and incubated in a 35-40 ℃ enzyme digester; the magnetic probe is separated by magnetic separation, washed with 80-95% acetonitrile / 1.0-2.0% trifluoroacetic acid buffer for 3-5 times, and eluted with 25-30% acetonitrile / 0.10-0.15% trifluoroacetic acid; 0.8-1.2 μL of the eluate is spotted on the MALDI-TOF-MS target plate, and after natural drying, 0.8-1.2 μL of a concentration of 15-25 A 2,5-dihydroxybenzoic acid (DHB) solution of 100 mg / mL was placed on the analyte droplet to form a thin layer of matrix, which was then dried for mass spectrometry analysis.
[0016] Specifically, the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion prepared by the present invention can be used for the enrichment and identification of glycopeptides in clinical serum samples (liver cancer patients and normal people) and the analysis of their glycosylation proteomics. After selective enrichment by the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion synthesized above, high-throughput mass spectrometry detection is performed, so that the signal intensity of glycosylated peptides that were originally unidentified is greatly improved to obtain clear glycosylated peptide signal peaks with high signal-to-noise ratio. This enrichment strategy has been implemented in many experiments such as standard HRP protease hydrolysate, HRP protease hydrolysate mixed solution with bovine serum albumin (BSA) and HRP protein, and normal human serum.
[0017] The beneficial effects of the present invention are:
[0018] The synthesis method of the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion is convenient and simple to operate. The successful introduction of magnetic nanospheres enables rapid magnetic separation of the material and the solution, greatly simplifying the experimental operation steps; the hydrophilic pore structure of the invention material with suitable size can separate and enrich glycosylated peptides on a large scale, and successfully eliminates the interference of other impurities such as large molecular proteins, and achieves satisfactory results in the identification of complex clinical samples (serum). By differentially analyzing the identified glycosylated proteins, liver cancer and normal people can be effectively distinguished. The experimental results fully prove that the magnetic nanoprobe prepared by the present invention has good stability and good biocompatibility, and is suitable for complex biological samples such as human serum, various tissue extracts, and various types of cell proteins. It has broad application prospects in large-scale analysis of glycosylated peptide samples. The nanoprobe can be used for the analysis and identification of glycosylated proteins in serum / urine samples of liver cancer patients of different types and periods, and can be used as a potential biomarker related to liver cancer detection. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 The synthetic flow chart of the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion.
[0020] Figure 2 (a) is a transmission electron micrograph of GO@Fe3O4 in Example 1; (b) is a transmission electron micrograph of GO@Fe3O4@MOF-303 in Example 1.
[0021] Figure 3 10 in Example 2 -6 Mass spectra of HRP enzymatic hydrolysate of M (a) and (b) after selective enrichment by magnetic nanoprobe modified with a metal-organic framework centered on aluminum ions.
[0022] Figure 4Mass spectra of the HRP protease hydrolysate, HRP protein and BSA protein mixed solution with a mass ratio of 1:1000:1000 in Example 3 (a), (b) before selective enrichment and (c), (d) after selective enrichment with the magnetic nanoprobe modified with an aluminum ion-centered metal organic framework.
[0023] Figure 5 Mass spectra of HRP hydrolysates of different concentrations in Example 4 after selective enrichment by magnetic nanoprobes modified with a metal organic framework centered on aluminum ions: (a) 10 fmol / μL, (b) 1 fmol / μL, (c) 0.5 fmol / μL and (d) 0.1 fmol / μL.
[0024] Figure 6 The magnetic nanoprobe modified with a metal organic framework with aluminum ion as the central ion in Example 5 was applied to the enrichment and separation of glycosylated peptides in clinical serum samples (liver cancer patients and normal subjects), (a) PLS-DA model analysis and (b) heat map analysis. DETAILED DESCRIPTION
[0025] Example 1: Synthesis of metal organic framework modified magnetic nanoprobes, the process is as follows Figure 1 As shown, the details are as follows:
[0026] (1) 100 mg of ferroferric oxide magnetic spheres with a size of 15 nm were dispersed in 25 mL of n-hexane solution containing 25 mg of graphene oxide. After ultrasonic dispersion for 2 hours, the material was obtained by magnetic separation.
[0027] (2) calcining the material obtained in step (1) at 500 °C for 2 h in a N2 atmosphere to obtain graphene oxide material loaded with ferroferric oxide spheres (GO@Fe3O4);
[0028] (3) Dissolve 0.75 g of 3,5-pyrazoledicarboxylic acid and 0.26 g of sodium hydroxide in 75 mL of pure water solution, sonicate for 1 h, and then preheat at 100 °C for 30 min.
[0029] (4) Add 1.04 g of aluminum chloride hexahydrate to the solution obtained in step (3), and sonicate until the solid is dissolved;
[0030] (5) dispersing the GO@Fe3O4 powder obtained in step (2) in the solution obtained in step (4), reacting at 100°C for 15 hours, and then magnetically separating the product, and then washing the product with deionized water and anhydrous ethanol for three times to obtain a metal organic framework modified magnetic nanoprobe GO@Fe3O4@MOF-303 with aluminum ions as the central ion, and vacuum drying at 50°C overnight;
[0031] Transmission electron microscope photos of GO@Fe3O4 are shown in Figure 2 (a); Transmission electron microscopy image of GO@Fe3O4@MOF-303 is shown in Figure 2 (b).
[0032] Example 2: The metal organic framework modified magnetic nanoprobe prepared in Example 1 was used for separation, enrichment and MALDI-TOF-MS detection of glycosylated peptides in standard HRP enzymatic hydrolysate.
[0033] (1) Preparation of standard HRP protease hydrolysate: accurately weigh 1 mg of standard protein HRP and dissolve it in 25 mM ammonium bicarbonate buffer, boil for 8 minutes, dilute to 1 mg / mL with 25 mM ammonium bicarbonate buffer, then add an appropriate amount of trypsin at a ratio of 1:40 to protein, and hydrolyze overnight at 37°C for 16 hours;
[0034] (2) 5 mg of the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion was washed three times with 95% acetonitrile / 1.0% trifluoroacetic acid buffer, then dispersed in 500 μL of 95% acetonitrile / 1.0% trifluoroacetic acid buffer, and ultrasonically dispersed until uniform to prepare a 10 mg / mL solution;
[0035] (3) Enrichment of glycosylated peptides: Take 50 μL of the solution obtained in step (2) and add 50 μL of 95% acetonitrile / 1.0% trifluoroacetic acid buffer; then add HRP standard protease digestion solution to make the peptide content 10 -6 M, incubate the reaction at 37 °C for 30 min; obtain a magnetic probe enriched with glycopeptides by magnetic separation, wash three times with 200 μL 95% acetonitrile / 1.0% trifluoroacetic acid buffer to remove non-glycopeptides and other impurities, then elute with 10 μL 30% acetonitrile / 0.1% trifluoroacetic acid buffer for 15 min, and obtain the eluted peptide solution by magnetic separation.
[0036] (4) Target spotting: Take 1 μL of the eluate in step (3) and spot it on the MALDI-TOF-MS target plate. After it is dried naturally in the air at room temperature, take 1 μL of 2,5-dihydroxybenzoic acid solution (20 mg / mL of 50% ACN solution) as a matrix and drop it on the analyte droplet to produce a thin matrix layer, which is then dried. Perform mass spectrometry analysis later.
[0037] like Figure 3 It can be seen that before enrichment, 10 -6 It is difficult to identify glycosylated peptides in the HRP standard protease hydrolysate of M, and the mass spectrum is mainly composed of non-glycopeptides ( Figure 3(a) However, after the action of the magnetic nanoprobe modified with a metal organic framework with aluminum ions as the central ion, 25 glycosylated peptide peaks of HRP protein appeared in the mass spectrum, and the signal peaks of glycosylated peptides were significantly enhanced ( Figure 3 (b)).
[0038] Example 3: The metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion obtained in Example 1 was used for the enrichment and MALDI-TOF-MS detection of HRP enzymatic hydrolysate and a mixed solution of HRP protein and bovine serum albumin (BSA) protein.
[0039] (1) HRP enzymatic hydrolysate was mixed with HRP and BSA protein solutions at a protein mass ratio of 1:1000:1000. 2 μL of the standard mixed solution was added to 150 μL of 95% acetonitrile / 1.0% trifluoroacetic acid buffer, and then 50 μL of a dispersion of aluminum ion-centered metal organic framework-modified magnetic nanoprobes (concentration of 10 mg / mL) was added. The mixture was incubated at 37°C for 30 min. The probes were separated by magnetic separation, washed three times with 200 μL of 95% acetonitrile / 1.0% trifluoroacetic acid buffer, eluted with 10 μL of 30% acetonitrile / 0.1% trifluoroacetic acid buffer for 15 min, and separated magnetically.
[0040] (2) Target spotting: Take 1 μL of the eluate described in step (2) and spot it onto the MALDI-TOF-MS target plate. After it is naturally dried in the air at room temperature, take 1 μL of 2,5-dihydroxybenzoic acid solution (20 mg / mL of 50% ACN solution) as a matrix and drop it on the analyte droplet to produce a thin matrix layer. After drying, perform mass spectrometry analysis.
[0041] like Figure 4 It can be seen that before enrichment, it is difficult to identify the glycosylated peptide peak in the mixed solution of HRP enzymatic hydrolysate and HRP protein and BSA protein at a mass ratio of 1:1000:1000 ( Figure 4 (a)); however, after the mixed solution was enriched by a magnetic nanoprobe modified with a metal organic framework with aluminum ions as the central ion, a large number of glycosylated peptide peaks were clearly shown in the mass spectrum ( Figure 4 (c)). In the linear mode of mass spectrometry, HRP protein and BSA protein were identified in the supernatant before enrichment ( Figure 4 (b)), while no protein signal peak was observed in the enriched eluate ( Figure 4 (d)).
[0042] Example 4: The metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion obtained in Example 1 was used for enrichment of ultra-low concentration HRP enzymatic hydrolyzate and MALDI-TOF-MS detection.
[0043] (1) Glycosylated peptide enrichment: 50 μL of a dispersion of a metal organic framework modified with aluminum ion as the central ion (concentration of 10 mg / mL) was added to 50 μL of 95% acetonitrile / 1.0% trifluoroacetic acid buffer; the standard protease hydrolysate was diluted with 25 mM ammonium bicarbonate buffer to a final concentration of 0.1 fmol / μL; incubated at 37 °C for 45 min; magnetically separated, washed three times with 200 μL of 95% acetonitrile / 1.0% trifluoroacetic acid buffer, eluted with 10 μL of 30% acetonitrile / 0.1% trifluoroacetic acid buffer for 15 min, and magnetically separated.
[0044] (2) Target spotting: Take 1 μL of the eluate described in step (1) and spot it onto the MALDI-TOF-MS target plate. After it is naturally dried in the air at room temperature, take 1 μL of 2,5-dihydroxybenzoic acid solution (20 mg / mL of 50% ACN solution) as a matrix and drop it on the analyte droplet to produce a thin matrix layer. After drying, perform mass spectrometry analysis.
[0045] like Figure 5 It can be seen that even when the concentration of HRP protease hydrolysate is as low as 0.1 fmol / μL, after enrichment by the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion, 6 glycosylated peptide peaks derived from HRP protein can still be clearly observed in the mass spectrometry ( Figure 5 (d)).
[0046] Example 5: The metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion obtained in Example 1 was used for the enrichment and nano-LC-MS / MS detection of glycosylated peptides in the enzymatic hydrolysis solution of clinical sample serum.
[0047] (1) Preparation of clinical serum enzymatic solution: 1 μL human serum was diluted to 20 μL with deionized water and centrifuged at 14,000 rpm for 15 minutes. The supernatant was collected and 10 mM dithiothreitol was added to react at 60°C for 30 minutes, followed by 20 mM indoleacetic acid and reacted at 37°C in the dark for 60 minutes. After cooling, acetone was added at a volume ratio of 1:6 to protein solution at -20°C for protein precipitation and reacted overnight for 12 hours. Before enzymatic hydrolysis, it was diluted with 50 mM ammonium bicarbonate solution to obtain a final protein solubility of 2 mg / mL. Then, an appropriate amount of trypsin was added to the supernatant at a protein weight ratio of 1:30 and enzymatic hydrolysis was performed at 37°C for 16 hours.
[0048] (2) Enrichment of glycosylated peptides: Take 200 μL of human serum enzymatic hydrolysate and 100 μL of a dispersion of metal organic framework-modified magnetic nanoprobes with aluminum ions as the central ion (concentration of 10 mg / mL), add them to 150 μL of 95% acetonitrile / 1.0% trifluoroacetic acid buffer, incubate at 37°C for 30 min; magnetic separation, wash three times with 300 μL of 95% acetonitrile / 1.0% trifluoroacetic acid buffer, elute with 20 μL of 30% acetonitrile / 0.1% trifluoroacetic acid buffer for 15 min, and magnetic separation.
[0049] (3) The eluted peptide samples were completely freeze-dried, and the dry powder was dissolved in 12 μL of chromatographic mobile phase A (0.1% formic acid aqueous solution), centrifuged at 17,000 rpm for 15 min, and the supernatant was aspirated; 8 μL was taken for injection, and the linear separation of chromatographic mobile phase B (0.1% formic acid acetonitrile solution) was set from 2% to 45%, and then eluted and analyzed at a flow rate of 300 nL / min.
[0050] Using a metal organic framework modified with aluminum ions as the central ion, magnetic nanoprobes were enriched, and a total of 274 glycosylated peptides and 101 glycosylated proteins were identified in normal human serum, and a total of 265 glycosylated peptides and 102 glycosylated proteins were identified in serum samples of liver cancer patients. The differences in glycosylated proteins identified between samples based on the PLS-DA model can clearly distinguish between normal human serum and serum samples of liver cancer patients ( Figure 6 ).
[0051] Example 6: The specific steps of the synthesis method of a metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion are the same as those of Example 1, except that the feeding amounts of 3,5-pyrazoledicarboxylic acid and sodium hydroxide in Example 1 (3) are reduced to 0.5 g and 0.175 g, respectively, and the feeding amount of aluminum chloride hexahydrate in Example 1 (4) is reduced to 0.695 g.
[0052] Example 7: The metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion obtained in Example 6 is used for the separation, enrichment and MALDI-TOF-MS detection of glycosylated peptides in standard HRP enzymatic hydrolyzate. The specific steps are the same as (1), (2), (3) and (4) in Example 2.
[0053] After enrichment with the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion obtained in Example 6, only 18 glycosylated peptide peaks of HRP protein appeared in the mass spectrum, indicating that the reduction of the MOF-303 coating amount has an adverse effect on the enrichment effect.
[0054] Example 8: The specific steps of the synthesis method of the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion are the same as those in Example 1.
[0055] Example 9: The metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion obtained in Example 8 was used for separation, enrichment and MALDI-TOF-MS detection of glycosylated peptides in standard HRP enzymatic hydrolyzate.
[0056] (1) Preparation of standard HRP protease hydrolysate is the same as (1) in Example 2;
[0057] (2) 5 mg of the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion was washed three times with 85% acetonitrile / 1.0% trifluoroacetic acid buffer, then dispersed in 500 μL of 85% acetonitrile / 1.0% trifluoroacetic acid buffer, and ultrasonically dispersed until uniform to prepare a 10 mg / mL solution;
[0058] (3) Enrichment of glycosylated peptides: Take 50 μL of the solution obtained in step (2) and add 50 μL of 85% acetonitrile / 1.0% trifluoroacetic acid buffer; then add HRP standard protease hydrolysate to make the peptide content 10-6 M, and incubate the reaction at 37°C for 30 minutes; obtain a magnetic probe enriched with glycopeptides by magnetic separation, wash three times with 200 μL of 85% acetonitrile / 1.0% trifluoroacetic acid buffer to remove non-glycopeptides and other impurities, then elute with 10 μL of 30% acetonitrile / 0.1% trifluoroacetic acid buffer for 15 minutes, and obtain the eluted peptide solution by magnetic separation.
[0059] (4) Target point: Same as (4) in Example 2
[0060] After enrichment of the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion obtained in Example 8, only 16 glycosylated peptide peaks of HRP protein appeared in the mass spectrum, indicating that this enrichment and elution condition has an adverse effect on the enrichment effect of the probe.
Claims
1. A method for synthesizing a metal organic framework modified magnetic nanoprobe with aluminum ions as the central ion, characterized in that: The specific steps are as follows: (1) Dispersing 50-200 mg of ferroferric oxide magnetic spheres with a size of 10-30 nm in 10-30 mL of n-hexane solution containing 20-50 mg of graphene oxide, ultrasonically dispersing for 1-4 hours, and magnetically separating the material; (2) calcining the material obtained in step (1) at 400-600°C for 2-6 hours in a nitrogen atmosphere, and the obtained material is recorded as GO@Fe3O4; (3) Dissolve 0.5-1 g 3,5-pyrazoledicarboxylic acid and 0.2-0.5 g sodium hydroxide in 50-150 mL pure aqueous solution, sonicate for 0.5-2 h, and then preheat at 100 °C for 30 min; the weight ratio of 3,5-pyrazoledicarboxylic acid to sodium hydroxide is 1:0.3-0.5; (4) adding 0.8-2.1 g of aluminum chloride hexahydrate to the solution obtained in step (3) and sonicating until dissolved; the weight ratio of aluminum chloride hexahydrate to 3,5-pyrazoledicarboxylic acid is 1.3-2.5:1; (5) The material obtained in step (2) is dispersed in the solution obtained in step (4), and the mixture is reacted at 25-100°C for 2-24 hours. The product is magnetically separated and washed with deionized water and anhydrous ethanol for 2-5 times, and vacuum dried at 40-80°C to obtain a metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion, which is denoted as GO@Fe3O4@MOF-303.
2. A magnetic nanoprobe modified with a metal organic framework having aluminum ions as the central ions obtained by the synthesis method of claim 1.
3. The use of the metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion in the selective separation, enrichment and mass spectrometry identification of glycosylated peptides as claimed in claim 2, characterized in that: The metal organic framework modified magnetic nanoprobe with aluminum ion as the central ion was fully mixed with the target glycosylated peptide solution, added into 80-95% acetonitrile / 1.0-2.0% trifluoroacetic acid buffer, dispersed evenly, and incubated in a 35-40 ℃ enzyme digester; the magnetic nanoprobe was separated by magnetic separation, washed 3-5 times with 80-95% acetonitrile / 1.0-2.0% trifluoroacetic acid buffer, and eluted with 25-30% acetonitrile / 0.10-0.15% trifluoroacetic acid; 0.8-1.2 μL of the eluate was spotted on the MALDI-TOF-MS target plate, and after natural drying, 0.8-1.2 μL of 2,5-dihydroxybenzoic acid DHB solution with a concentration of 15-25 mg / mL was added dropwise onto the analyte droplet to form a thin layer of matrix, which was then dried for mass spectrometry analysis.
